RedHill (RDHL) Down on Unsatisfactory Data From COVID-19 Study

Published on September 15, 2021

RedHill (RDHL) posts preliminary top-line data from a phase II/III study evaluating opaganib in hospitalized patients with severe COVID-19 pneumonia....